SANUWAVE Health, Inc. (SNWV) stock
SNWVNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$1.70−0.11 (-6.08%)
Close on Nov 17, 2026Market cap $14.62MP/E –Yield –
SANUWAVE Health profit margin
Profit margin (net margin) is net income as a percentage of revenue.
SANUWAVE Health's profit margin for the twelve months ending Jun 30, 2026 was 34.7%. For fiscal 2025 it was 26.8%, against -101.4% the year before. The highest annual figure on record is 26.8% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 26.8% | +128.2 |
| FY2024 | Dec 31, 2024 | -101.4% | +25.1 |
| FY2023 | Dec 31, 2023 | -126.5% | −65.0 |
| FY2022 | Dec 31, 2022 | -61.5% | +148.0 |
| FY2021 | Dec 31, 2021 | -209.5% | +553.0 |
| FY2020 | Dec 31, 2020 | -762.6% | +251.3 |
| FY2019 | Dec 31, 2019 | -1013.9% | −385.2 |
| FY2018 | Dec 31, 2018 | -628.7% | +121.2 |
| FY2017 | Dec 31, 2017 | -749.9% | −281.9 |
| FY2016 | Dec 31, 2016 | -467.9% | +30.3 |
| FY2015 | Dec 31, 2015 | -498.2% | +206.8 |
| FY2014 | Dec 31, 2014 | -705.0% | +707.4 |
| FY2013 | Dec 31, 2013 | -1412.4% | −580.2 |
| FY2012 | Dec 31, 2012 | -832.2% | +443.5 |
| FY2011 | Dec 31, 2011 | -1275.7% | +772.8 |
| FY2010 | Dec 31, 2010 | -2048.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -7.0% | −12.5 |
| Q1 FY2026 | Mar 31, 2026 | -15.0% | +50.6 |
| Q4 FY2025 | Dec 31, 2025 | 57.4% | +186.3 |
| Q3 FY2025 | Sep 30, 2025 | 86.0% | +312.1 |
| Q2 FY2025 | Jun 30, 2025 | 5.5% | −80.9 |
| Q1 FY2025 | Mar 31, 2025 | -65.6% | +17.4 |
| Q4 FY2024 | Dec 31, 2024 | -128.9% | −389.6 |
| Q3 FY2024 | Sep 30, 2024 | -226.1% | +252.4 |
| Q2 FY2024 | Jun 30, 2024 | 86.4% | +241.7 |
| Q1 FY2024 | Mar 31, 2024 | -82.9% | +263.6 |
| Q4 FY2023 | Dec 31, 2023 | 260.7% | +364.3 |
| Q3 FY2023 | Sep 30, 2023 | -478.5% | −451.2 |
| Q2 FY2023 | Jun 30, 2023 | -155.3% | −197.7 |
| Q1 FY2023 | Mar 31, 2023 | -346.5% | −186.8 |
| Q4 FY2022 | Dec 31, 2022 | -103.6% | +118.4 |
| Q3 FY2022 | Sep 30, 2022 | -27.3% | +86.8 |
| Q2 FY2022 | Jun 30, 2022 | 42.3% | +338.5 |
| Q1 FY2022 | Mar 31, 2022 | -159.7% | +73.7 |
| Q4 FY2021 | Dec 31, 2021 | -221.9% | +252.4 |
| Q3 FY2021 | Sep 30, 2021 | -114.1% | +811.0 |
| Q2 FY2021 | Jun 30, 2021 | -296.1% | +4079.8 |
| Q1 FY2021 | Mar 31, 2021 | -233.3% | +1781.4 |
| Q4 FY2020 | Dec 31, 2020 | -474.3% | +343.8 |
| Q3 FY2020 | Sep 30, 2020 | -925.2% | +465.2 |
| Q2 FY2020 | Jun 30, 2020 | -4375.9% | −3513.2 |
| Q1 FY2020 | Mar 31, 2020 | -2014.8% | −780.1 |
| Q4 FY2019 | Dec 31, 2019 | -818.1% | −366.8 |
| Q3 FY2019 | Sep 30, 2019 | -1390.4% | −1251.9 |
| Q2 FY2019 | Jun 30, 2019 | -862.7% | −225.4 |
| Q1 FY2019 | Mar 31, 2019 | -1234.7% | +466.5 |
| Q4 FY2018 | Dec 31, 2018 | -451.3% | +426.7 |
| Q3 FY2018 | Sep 30, 2018 | -138.5% | +388.4 |
| Q2 FY2018 | Jun 30, 2018 | -637.3% | +637.8 |
| Q1 FY2018 | Mar 31, 2018 | -1701.2% | −1371.2 |
| Q4 FY2017 | Dec 31, 2017 | -877.9% | −499.3 |
| Q3 FY2017 | Sep 30, 2017 | -526.9% | −81.0 |
| Q2 FY2017 | Jun 30, 2017 | -1275.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -330.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -378.7% | – |
| Q3 FY2016 | Sep 30, 2016 | -445.8% | – |
See a number that looks wrong?